Results: After 24 weeks, the success rate of the implant for maintenance of IGF-1 and GH levels was 86% (95% CI: 80.3%) compared to 84% (95% CI: 73.8%) for octreotide LAR.
结果：24周后，与奥曲肽类似物维持igf—1和GH水平的成功率为84% (95%CI： 73.8%)相比，奥曲肽植入物的成功率为86% (95% CI： 80.3%)。
Results: After 24 weeks, the success rate of the implant for maintenance of IGF-1 and GH levels was 86% (95% CI: 80.3%) compared to 84% (95% CI: 73.8%) for octreotide LAR.
结果：24周后，与奥曲肽类似物维持igf—1和GH水平的成功率为84% (95%CI： 73.8%)相比，奥曲肽植入物的成功率为86% (95% CI： 80.3%)。
应用推荐